Tanya Lewis Replimune Group, Inc. (REPL) insider trading activity

Tanya Lewis is Chief Dev. Op. Officer of Replimune Group, Inc.. Currently has a direct ownership of 135,293 shares of REPL, which is worth approximately $1.1 Million. The most recent transaction as insider was on Jun 13, 2023, when has been sold 12,860 shares (Common Stock) at a price of $23.78 per share, resulting in proceeds of $305,810. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K

0% 3M change

0% 12M change

Total Value Held $1.1 Million

Tanya Lewis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2023	SELL Open market or private sale	$305,810 $23.78 p/Share	12,860 Reduced 8.68%	135,293 Common Stock
May 16 2023	SELL Open market or private sale	$220,336 $18.05 p/Share	12,207 Reduced 7.61%	148,153 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	40,000 Added 19.96%	160,360 Common Stock
May 16 2022	SELL Open market or private sale	$79,851 $14.59 p/Share	5,473 Reduced 4.35%	120,360 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	52,500 Added 29.44%	125,833 Common Stock
May 10 2021	BUY Grant, award, or other acquisition	-	73,333 Added 50.0%	73,333 Common Stock

Also insider at

KPTI

Karyopharm Therapeutics Inc. Healthcare

EVP, Chief Reg. Affairs

DMAC

DiaMedica Therapeutics Inc. Healthcare

Director

Tanya Lewis

Chief Dev. Op. Officer

Woburn, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Value

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL

Account